Search

For Advocacies & GPs

d46da857dd7a6393c8c7804fd3cbd8773967736c
into...
... the wealth and depth of the cutting-edge work of our outstanding Investigators.
... the latest breakthroughs in early diagnostics and surgical advances.
... a much enhanced public influence by leveraging our combined strength to lobby Regulators, Institutional Actors and Policymakers to recommend amendments to present problematic regulatory standards and to propose actionable policy recommendations.
... the possibility to cross check with us treatment options emerging from the latest pipelines in PDAC research.

Our Working Group on Patients Representation, Advocacies & Global Partnerships is the place to start. We will also keep you up to date with experimental clinical trials and compassionate use (expanded access).

TAPCA firmly believes that Patients advocacy and their relationship with their General Practitioners are an integral aspect of any pancreatic cancer treatment, especially if Patient care is to be improved significantly.

Notably, TAPCA aims to create the

World's Largest Patients Registry in PDAC

because the larger the assembling of clinical data from Patients, the faster our labs will get to treatment breakthroughs in this digital and AI era. The Registry will also significantly speed up our clinical trials, which we aim to run in multiple locations simultaneously, again bolstering the delivery of new treatments. Here, intense cooperation between you and us will play a pivotal and life extending role for Patients.

To reach out, please go to

Contacts